Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$843,688
+$60,503 QoQ
Shares Held
3,322
+3.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#3,164
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Souders Financial Advisors holds $13,208,144 across 10 Drug Manufacturers - General names. JNJ ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,235 | $5,079,586 | |
| 2 | ABBV |
AbbVie Inc.
|
8,246 | $2,075,023 | |
| 3 | AMGN |
Amgen Inc
|
5,104 | $1,848,260 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,395 | $1,592,757 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
3,322 | $843,688 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,223 | $407,193 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,899 | $397,520 | |
| 8 | AZN |
Astrazeneca PLC
|
1,928 | $365,587 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $843,688 | 3,322 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $783,185 | 3,204 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $550,487 | 2,660 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $459,285 | 2,477 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $330,245 | 2,162 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $508,299 | 3,065 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $328,576 | 2,272 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $339,515 | 2,095 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $308,689 | 2,112 | Shares | Sole | 2024-08-28 | |
| 2024-03-31 | $326,504 | 2,064 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,038,715 | 6,627 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,101,931 | 7,075 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $1,652,551 | 9,984 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,436,385 | 9,267 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $1,584,727 | 8,971 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,438,384 | 8,805 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,578,773 | 8,894 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,057,531 | 5,967 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,025,393 | 5,994 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,249,525 | 7,737 | Shares | Sole | 2021-11-03 | |
| 2021-06-30 | $1,161,581 | 7,051 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $1,161,954 | 7,070 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $673,586 | 4,280 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $622,913 | 4,184 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $535,800 | 3,810 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $577,103 | 4,401 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||